FISH Testing Probes Market Size in 2022, Increasing demand, Growth strategies, Forecast to 2028

Fluorescent in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes that bind to only those parts of the chromosome with a high degree of sequence complementarity. FISH Testing Probes can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the HER2 gene.Report OverviewDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of percent during the forecast period 2022-2028.The USA market for FISH Testing Probes is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The China market for FISH Testing Probes is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The Europe market for FISH Testing Probes is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The global key manufacturers of FISH Testing Probes include Oxford Gene Technology, Enzo Biochem, Abbott, BioCat GmbH, Empire Genomics, Cytocell, GeneCopoeia, ZytoVision and Abnova, etc. In 2021, the global top five players had a share approximately percent in terms of revenue.